SC Filed 2024-02-20 Event — SEC 0001104659-24-025667 →

Sofinnova Venture Partners IX, L.P. → Galera Therapeutics, Inc. GRTX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 1.00

7,365 shares short · +9.6% vs prior

Other 13D/G Filings on Galera Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-11	SCHEDULE 13D	Hyare Parvinder Singh	6.65%	13,521,921	view →
2026-05-29	SCHEDULE 13D/A	Emerald Bioventures, LLC	30.20%	61,029,978	view →
2026-04-27	SCHEDULE 13D	Emerald Bioventures, LLC	26.50%	40,216,160	view →
2026-04-10	SCHEDULE 13D	CHANG NANCY T	5.90%	8,921,543	view →

Other Filings by Sofinnova Venture Partners IX, L.P.

Filed	Form	Issuer	Stake	Shares
2021-03-04	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2020-06-05	SC	Iterum Therapeutics plc ITRMF	—	—	view →
2020-04-27	SC	Merus N.V.	—	—	view →
2020-01-27	SC	Iterum Therapeutics plc ITRMF	—	—	view →
2019-11-22	SC	NextCure, Inc. NXTC	—	—	view →
2019-02-12	SC	aTYR PHARMA INC ATYR	—	—	view →
2019-02-12	SC	Ascendis Pharma A/S ASND	—	—	view →
2019-01-11	SC	Ascendis Pharma A/S ASND	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →